ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,166, issued on Nov. 18, was assigned to Stichting VUmc (Amsterdam).
"Inhibition of mycobacterial type VII secretion" was invented by Eelco Ruijter (Amsterdam), Mark Karsten Rong (Amsterdam), Alexander Speer (Amsterdam), Wilhelmus Bitter (Amsterdam) and Stewart Thomas Cole (Amsterdam).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compounds and pharmaceutically acceptable salts thereof, and to their medical use. Exemplary medical uses are the prevention and treatment of a bacterial infection, for example, a mycobacterial infection, such as a Mycobacterium tuberculosis infection, e.g., in a respiratory system and/or extrapulmon...